An Investigator Initiated Phase II Clinical Trial of Tamibarotene (AM80G) for Chronic Graft-Versus-Host Disease

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
doi 10.4044/joma.127.133
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Okayama Medical Association